Modeling Congenital Heart Disease Using Pluripotent Stem Cells.

Area of Science:

• Cardiovascular Biology
• Stem Cell Biology
• Developmental Biology

Background:

• Congenital heart disease (CHD) is a leading cause of birth defects, often necessitating early surgical intervention.
• Understanding the underlying mechanisms of CHD is crucial for improving patient outcomes.
• Basic science approaches are essential for dissecting the complex etiology of cardiac malformations.

Purpose of the Study:

• To review recent advancements in utilizing human-induced pluripotent stem cells (hiPSCs) for studying CHD.
• To elucidate the mechanistic insights gained from hiPSC-derived cardiovascular cells regarding CHD.
• To explore the potential of hiPSC technology in developing diagnostic and therapeutic strategies for CHD.

Main Methods:

• Utilizing human-induced pluripotent stem cells (hiPSCs) to generate cardiovascular derivative cell types.
• Investigating genetic and epigenetic abnormalities in hiPSC-derived cells relevant to CHD.
• Analyzing in vitro defects in hiPSC differentiation, signaling pathways, and transcriptional activity.

Main Results:

• hiPSC-derived cardiomyocytes successfully replicate genetic and epigenetic irregularities associated with CHD.
• Observed defects in hiPSC differentiation, cellular signaling, and transcriptional activity in vitro.
• Demonstrated the utility of hiPSC models in recapitulating key aspects of CHD pathophysiology.

Conclusions:

• hiPSC technology provides a powerful platform for mechanistic interrogation of CHD.
• Findings highlight the role of genetic and epigenetic factors in CHD development.
• hiPSC-derived cells offer potential for developing early in utero screening and innovative postnatal therapies for CHD.